首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003–2004
【24h】

Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003–2004

机译:2003年至2004年,针对6至59个月的儿童进行的医学确诊,实验室确认的流感疫苗的有效性

获取原文
获取外文期刊封面目录资料

摘要

OBJECTIVES. Influenza is a leading cause of illness among children. Studies rarely have measured influenza vaccine effectiveness among young children, particularly when antigenic match between vaccine and circulating viruses is suboptimal. We assessed vaccine effectiveness against medically attended, laboratory-confirmed influenza for children who were aged 6 to 59 months during the 2003–2004 influenza season.METHODS. In a case-control study that was conducted in a single pediatric practice, case patients who were aged 6 to 59 months and had laboratory-confirmed influenza were age matched 1:2 to eligible control subjects. Vaccination status was ascertained as of the date of the case patient’s symptom onset. Conditional logistic regression was used to calculate vaccine effectiveness, adjusting for underlying medical conditions and health care usage.RESULTS. We identified 290 influenza case patients who were seen for medical care from November 1, 2003, to January 31, 2004. Vaccine effectiveness among fully vaccinated children, compared with unvaccinated children, was 49%. Partially vaccinated children who were aged 6 to 23 months had no significant reduction in influenza (vaccine effectiveness: ?70%), but partially vaccinated children who were aged 24 to 59 months had a significant (65%) reduction in influenza, compared with unvaccinated children.CONCLUSIONS. Full vaccination provided measurable protection against laboratory-confirmed influenza among children who were aged 6 to 59 months during a season with suboptimal vaccine match. No vaccine effectiveness was identified with partial vaccination among children who were aged 6 to 23 months, affirming that children need to be fully vaccinated to obtain protective effects. These results strengthen the evidence of the vaccine’s ability to reduce substantially the burden of disease in this age group.
机译:目标流感是儿童患病的主要原因。很少有研究测量幼儿中流感疫苗的有效性,尤其是当疫苗和正在传播的病毒之间的抗原匹配不够理想时。我们评估了针对2003-2004年流感季节6至59个月大的儿童进行医学确诊,实验室确认的流感疫苗的有效性。在一项单独的儿科实践中进行的病例对照研究中,年龄在6至59个月之间且实验室确诊为流感的病例患者与符合条件的对照对象的年龄匹配为1:2。从该病例患者症状发作之日起确定疫苗接种状态。有条件的逻辑回归用于计算疫苗的有效性,并针对基本的医疗条件和医疗保健用途进行调整。我们确定了从2003年11月1日至2004年1月31日就诊的290例流感病例患者。完全接种疫苗的儿童与未接种疫苗的儿童相比,疫苗的有效率为49%。与未接种疫苗相比,年龄在6至23个月的部分接种疫苗的儿童的流感没有明显减少(疫苗有效性:?70%),但是在24-59个月年龄的部分接种疫苗的儿童的流感减少了(65%)儿童。结论。完全疫苗接种可为接种不良疫苗的季节中6至59个月大的儿童提供针对实验室确诊流感的可测量保护。在6至23个月大的儿童中,未通过部分疫苗接种确认疫苗有效,这表明需要充分接种儿童以获得保护作用。这些结果进一步证明了该疫苗能够大大减轻该年龄组疾病负担的能力。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号